Document is current
Any future updates will be listed below
-
Authors
Schuhmacher, Juliane
Heidu, Sonja
Balchen, Torben
Richardson, Jennifer Rebecca
Schmeltz, Camilla
Sonne, Jesper
Schweiker, Jonas
Rammensee, Hans-Georg
Thor Straten, Per
Røder, Martin Andreas
Brasso, Klaus
Gouttefangeas, Cécile https://orcid.org/0000-0002-6410-2378
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03199872 at ClinicalTrials.govnct04114825 at ClinicalTrials.govDocuments that mention this clinical trial
Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial
https://doi.org/10.1136/jitc-2020-001157
Documents that mention this clinical trial
Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial
https://doi.org/10.1136/jitc-2020-001157
-
Funding
Funding for this research was provided by:
RhoVac ApS
- License Information
